New anxiety drug shows promise in early trial
NCT ID NCT06653296
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 37 times
Summary
This study tested a new medicine called ENX-102 in 38 adults with generalized anxiety disorder (GAD). The goal was to see if it is safe and to find the best dose. Participants received either the drug or a placebo, and researchers monitored side effects and anxiety symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERAL ANXIETY DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
MAC Clinical Research
Liverpool, UK, United Kingdom
-
MAC Clinical Research
Blackpool, United Kingdom
-
MAC Clinical Research
Manchester, United Kingdom
Conditions
Explore the condition pages connected to this study.